𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest

✍ Scribed by Yong Hwan Han; Sung Zoo Kim; Suhn Hee Kim; Woo Hyun Park

Book ID
116919877
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
354 KB
Volume
22
Category
Article
ISSN
0887-2333

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A superoxide anion generator, pyrogallol
A superoxide anion generator, pyrogallol, inhibits the growth of HeLa cells via cell cycle arrest and apoptosis
✍ Sang WooK Kim; Yong Whan Han; Soo Teik Lee; Hey Jin Jeong; Seong Hun Kim; In Hee πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 647 KB

## Abstract We investigated the in vitro effects of pyrogallol on cell growth, cell cycle regulation, and apoptosis in HeLa cells. Pyrogallol inhibited the growth of HeLa cells with an IC~50~ of approximately 45 Β΅M. Pyrogallol induced arrest during all phases of the cell cycle and also very efficie

Pyrogallol inhibits the growth of human
Pyrogallol inhibits the growth of human pulmonary adenocarcinoma A549 cells by arresting cell cycle and triggering apoptosis
✍ Yong Hwan Han; Suhn Hee Kim; Sung Zoo Kim; Woo Hyun Park πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 126 KB

## Abstract Pyrogallol (PG) is a polyphenol compound and has been known to be an O generator. We evaluated the effects of PG on the growth of human pulmonary A549 cells in relation to the cell cycle and apoptosis. Treatment with 50 or 100 ΞΌM PG significantly inhibited the cell growth of A549 for 72

Gefitinib Inhibits the Proliferation of
Gefitinib Inhibits the Proliferation of Pancreatic Cancer Cells via Cell Cycle Arrest
✍ Xiaohua Zhou; Maqing Zheng; Fang Chen; Yunxia Zhu; Wei Yong; Haiyan Lin; Yujie S πŸ“‚ Article πŸ“… 2009 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 281 KB πŸ‘ 2 views

## Abstract High expression of the epidermal growth factor receptor (EGFR) has been implicated in the development of pancreatic cancer. Gefitinib is an orally active and selective EGFR‐TKI (EGFR‐tyrosine kinase inhibitor) that blocks signal transduction pathways responsible for the proliferation an